Details for New Drug Application (NDA): 019557
✉ Email this page to a colleague
The generic ingredient in VEPESID is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.
Summary for 019557
Tradename: | VEPESID |
Applicant: | Strides Pharma |
Ingredient: | etoposide |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019557
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Dec 30, 1986 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Dec 30, 1986 | TE: | RLD: | Yes |
Expired US Patents for NDA 019557
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-001 | Dec 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-002 | Dec 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription